Related references
Note: Only part of the references are listed.Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts
Hirotaka Iwaki et al.
NEUROLOGY-GENETICS (2019)
Integrated analysis of gene expression signatures associated with colon cancer from three datasets
Ping Gao et al.
GENE (2018)
Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood
Ting Qi et al.
NATURE COMMUNICATIONS (2018)
Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
Xianjun Dong et al.
NATURE NEUROSCIENCE (2018)
Coding variation in GBA explains the majority of the SYT11-GBA Parkinson's disease GWAS locus
Cornelis Blauwendraat et al.
MOVEMENT DISORDERS (2018)
Nectin-like 4 Complexes with Choline Transporter-like Protein-1 and Regulates Schwann Cell Choline Homeostasis and Lipid Biogenesis in Vitro
Corey Heffernan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal
Victoria Berge-Seidl et al.
NEUROSCIENCE LETTERS (2017)
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease
Shuchi Mittal et al.
SCIENCE (2017)
Functional mapping and annotation of genetic associations with FUMA
Kyoko Watanabe et al.
NATURE COMMUNICATIONS (2017)
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Ganqiang Liu et al.
ANNALS OF NEUROLOGY (2016)
RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data
Xiaowei Zhan et al.
BIOINFORMATICS (2016)
Next-generation genotype imputation service and methods
Sayantan Das et al.
NATURE GENETICS (2016)
Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression
Albert A. Davis et al.
NEUROBIOLOGY OF AGING (2016)
APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression
Kimberly C. Paul et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease
Marie Y. Davis et al.
JAMA NEUROLOGY (2016)
Mechanism of choline deficiency and membrane alteration in postural orthostatic tachycardia syndrome primary skin fibroblasts
Laila C. Schenkel et al.
FASEB JOURNAL (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases
Mike A. Nalls et al.
NEUROBIOLOGY OF AGING (2015)
GBA-Associated Parkinson's Disease: Reduced Survival and More Rapid Progression in a Prospective Longitudinal Study
Kathrin Brockmann et al.
MOVEMENT DISORDERS (2015)
Staying awake - a genetic region that hinders α2 adrenergic receptor agonist-induced sleep
Cigdem Gelegen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
APOE, MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease
Ignacio F. Mata et al.
JAMA NEUROLOGY (2014)
Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort
Sophie E. Winder-Rhodes et al.
BRAIN (2013)
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease
Margaux F. Keller et al.
HUMAN MOLECULAR GENETICS (2012)
A large study reveals no association between APOE and Parkinson's disease
Monica Federoff et al.
NEUROBIOLOGY OF DISEASE (2012)
LocusZoom: regional visualization of genome-wide association scan results
Randall J. Pruim et al.
BIOINFORMATICS (2010)
METAL: fast and efficient meta-analysis of genomewide association scans
Cristen J. Willer et al.
BIOINFORMATICS (2010)
Integrating common and rare genetic variation in diverse human populations
David M. Altshuler et al.
NATURE (2010)
APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
Martin Wilhelm Kurz et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2009)
Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS, and its role in choline uptake
Eva Machova et al.
JOURNAL OF NEUROCHEMISTRY (2009)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): Process, format, and clinimetric testing plan
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2007)
Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease - A possible neuroprotective role for noradrenaline
Junchao Tong et al.
ARCHIVES OF NEUROLOGY (2006)
Apolipoprotein e and dementia in Parkinson disease -: A meta-analysis
XM Huang et al.
ARCHIVES OF NEUROLOGY (2006)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2004)
Treatment with α2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats:: neurochemical and behavioral evidence
J Srinivasan et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Share Paper
